Financing for Bridgepoint acquisition of GBA Group
We are advising the lenders on the transaction
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
REGENXBIO $115 million equity offering
We advised the joint book-running managers and underwriters on the offering
Ascentage Pharma $200 million at-the-market offering
We advised the sales agents on the offering
GenFleet Therapeutics HK$471.8 million placement of new H shares
We advised GenFleet Therapeutics on the placement
Penguin Solutions $750M convertible notes offering and capped call transactions
We advised the initial purchasers on the offering
Standard Nuclear $150 million IPO
We advised the underwriters on the IPO
Uniti Group $1.1 billion fiber securitization notes offering
We advised Uniti on its second fiber-to-the-home securitization notes offering
ENGIE Brasil R$8.4 billion equity offering
We advised the joint bookrunners on the offering
Over $7.2 billion of hybrid and structured capital financings in H1 2026
We advised on 36 transactions for a broad range of borrower and lender counterparties
Lightyear Capital strategic investment in Prosperity Partners
We are advising Lightyear Capital on the transaction